Register for a Clinical Trial

Protocol GA29102
Title Evaluate the Efficacy and Safety of Etrolizumab compared with Placebo in Patients with Moderate to Severe Active Ulcerative Colitis who are Naive to TNF Inhibitors.
Phase III
Area Ulcerative Colitis
Indication

Ulcerative Colitis

Treatment

Etrolozumab vs Placebo

Requirement

Naive to TNF Inhibitors

Inadequate response, loss of response, or intolerance to prior immunosuppressants treatment: AZA, 6-MP, or MTX

Trial:
Your First Name:
Your Last Name:
Phone Number:
Address:
City:
State:
ZIP Code:
E-mail Address:
Cancel